Pfizer Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€32.40
Target price
02.08.24
€40.22
Performance (%)
-15.59%
End price
03.08.24
€27.35
Summary
This prediction ended on 03.08.24 with a price of €27.35. The prediction for Pfizer Inc. disappointed with a performance of -15.59%. BMO_Capital_Markets has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. A total of €1.93 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 3.107% | 3.107% | -1.008% |
| iShares Core DAX® | -2.526% | -5.194% | 4.911% |
| iShares Nasdaq 100 | -0.032% | 1.561% | 21.789% |
| iShares Nikkei 225® | -4.202% | -7.550% | 31.128% |
| iShares S&P 500 | -0.802% | 0.160% | 15.782% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten